"Female Viagra": Behind the Hype | The Body of Evidence

"Female Viagra": Behind the Hype

Casanova used oysters and chocolate to put his female companions in the mood. They don’t actually do anything, though. I eat them all the time and have yet to become the ladies’ man I always thought I would be.

So the promise of something that may act as an aphrodisiac would be a financial blockbuster for its manufacturer.

Enter flibanserin (soon to be rebranded as Addyi), which was just approved by the U.S. Food and Drug Administration and seems likely to be approved by Health Canada soon enough. It is the first medication indicated to treat hypoactive sexual desire disorder (HSDD) in women.

Only problem is, many experts contend that HSDD doesn’t actually exist, that the drug is ineffective, has terrible side effects and was approved only because of a successful lobbying campaign.

It’s kind of a funny story.

To read the rest of Dr. Labos' article in the Montreal Gazette, click here!